mesalamine has been researched along with Esophagitis in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Esophagitis: INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Surawicz, CM | 1 |
1 review available for mesalamine and Esophagitis
| Article | Year |
|---|---|
Ulcerative colitis and cytomegaloviral esophagitis: two diseases, two randomized, controlled trials.
Topics: Antiviral Agents; Ciprofloxacin; Colitis, Ulcerative; Cytomegalovirus Infections; Drug Therapy, Comb | 1999 |